IL222870B - Ccl1-ig fusion polypeptide for use in therapy - Google Patents

Ccl1-ig fusion polypeptide for use in therapy

Info

Publication number
IL222870B
IL222870B IL222870A IL22287012A IL222870B IL 222870 B IL222870 B IL 222870B IL 222870 A IL222870 A IL 222870A IL 22287012 A IL22287012 A IL 22287012A IL 222870 B IL222870 B IL 222870B
Authority
IL
Israel
Prior art keywords
ccl1
therapy
fusion polypeptide
polypeptide
fusion
Prior art date
Application number
IL222870A
Other languages
Hebrew (he)
Other versions
IL222870A0 (en
Inventor
Wildbaum Gizi
Karin Nathan
Barsheshet Yiftah
Original Assignee
Rappaport Family Institute For Res In The Medical Sciences
Wildbaum Gizi
Karin Nathan
Barsheshet Yiftah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2011/000361 external-priority patent/WO2011138785A2/en
Application filed by Rappaport Family Institute For Res In The Medical Sciences, Wildbaum Gizi, Karin Nathan, Barsheshet Yiftah filed Critical Rappaport Family Institute For Res In The Medical Sciences
Priority to IL222870A priority Critical patent/IL222870B/en
Publication of IL222870A0 publication Critical patent/IL222870A0/en
Publication of IL222870B publication Critical patent/IL222870B/en

Links

IL222870A 2010-05-05 2012-11-05 Ccl1-ig fusion polypeptide for use in therapy IL222870B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL222870A IL222870B (en) 2010-05-05 2012-11-05 Ccl1-ig fusion polypeptide for use in therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33143810P 2010-05-05 2010-05-05
PCT/IL2011/000361 WO2011138785A2 (en) 2010-05-05 2011-05-05 Use of ccl1 in therapy
IL222870A IL222870B (en) 2010-05-05 2012-11-05 Ccl1-ig fusion polypeptide for use in therapy

Publications (2)

Publication Number Publication Date
IL222870A0 IL222870A0 (en) 2012-12-31
IL222870B true IL222870B (en) 2018-12-31

Family

ID=47633788

Family Applications (1)

Application Number Title Priority Date Filing Date
IL222870A IL222870B (en) 2010-05-05 2012-11-05 Ccl1-ig fusion polypeptide for use in therapy

Country Status (1)

Country Link
IL (1) IL222870B (en)

Also Published As

Publication number Publication date
IL222870A0 (en) 2012-12-31

Similar Documents

Publication Publication Date Title
HK1192587A1 (en) Therapeutic fusion proteins
EP2638072A4 (en) Fusion proteins for hiv therapy
HK1199889A1 (en) Relaxin fusion polypeptides and uses thereof
EP2728002A4 (en) Heterodimerized polypeptide
IL279676A (en) Recombinant proteins and their therapeutic uses
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
SG184289A1 (en) Novel peptides and methods for their preparation and use
IL222382A0 (en) Robo1-fc fusion protein and use thereof for treating tumours
IL222027A (en) Peptides and their use
SG10201500208SA (en) Npp1 fusion proteins
ZA201400562B (en) Axmi205 variant proteins and methods for their use
EP2711376A4 (en) Fgfr-fc fusion protein and use thereof
EP2605786A4 (en) Therapeutic peptides
GB2498325B (en) Engineered human GRM6 enhancer sequence for use in eye therapies
IL226805B (en) Cd89 activation in therapy
EP2698386A4 (en) Fusion protein
EP2683742A4 (en) Npp1 fusion proteins
ZA201305266B (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
EP2657337A4 (en) Fusion protein
EP2631249A4 (en) Fusion protein having factor ix activity
GB201016494D0 (en) Polypeptide
EP2762149A4 (en) Erythropoietin-derived peptide and use therefor
ZA201207425B (en) Fusion protein
IL222870B (en) Ccl1-ig fusion polypeptide for use in therapy
GB201020792D0 (en) Peptide agents for use in therapy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed